Membres de l'équipe

Kunduzova
Oksana
(CR1)

Kunduzova Oksana (CR1)

Oxana.Koundouzova@inserm.fr

05 31 22 41 24

Tronchère
Hélène
(CR1)

Tronchère Hélène (CR1)

helene.tronchere@inserm.fr

05 31 22 41 17

Boal
Frédéric
(CR1)

Boal Frédéric (CR1)

frederic.boal@inserm.fr

05 31 22 41 17

Maupas-Schwalm
Françoise
(MCU-PH)

Maupas-Schwalm Françoise (MCU-PH)

Marsal
Dimitri
(AI)

Marsal Dimitri (AI)

dimitri.marsal@inserm.fr

05 31 22 41 17

Arnaut
Oleg
(Post-Doc)

Arnaut Oleg (Post-Doc)

Timotin
Andrei
(Doc)

Timotin Andrei (Doc)

andrei.timotin@inserm.fr

05 31 22 41 17

Cinato
Mathieu
(Doc)

Cinato Mathieu (Doc)

mathieu.cinato@inserm.fr

05 31 22 40 90

Timercan
Tatiana
(Doc)

Timercan Tatiana (Doc)

tatiana.timercan@inserm.fr

05 31 22 41 17

Missiak
Yohann
(Doc)

Missiak Yohann (Doc)

Merabishvili
Giorgi
(M2)

Merabishvili Giorgi (M2)

PMIDTitreAuteursAnnéeJournal
31836542In vitro and in vivo cardioprotective and metabolic efficacy of vitamin E TPGS/ApelinLeme Goto, Patricia Cinato, Mathieu Merachli, Fadi Vons, Bohdana Jimenez, Tony Marsal, Dimitri Todua, Nika Loi, Halyna Santin, Yohan Cassel, Stéphanie Blanzat, Muriel Tronchere, Hele2020Journal of Molecular and Cellu
30873028Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial InfarctionLoi, Halyna Boal, Frederic Tronchere, Helene Cinato, Mathieu Kramar, Solomiia Oleshchuk, Oleksandra Korda, Mykhaylo Kunduzova, Oksana2019Frontiers in Pharmacology
29784904Differential protein profiling as a potential multi-marker approach for obese patients with heart failure: A retrospective studyTimotin, Andrei Cinato, Mathieu Boal, Frederic Dejean, Sebastien Anesia, Rodica Arnaut, Oleg Lagente, Christine Roncalli, Jerome Desmoulin, Franck Tronchere, Helene Kunduzova, Oksana2018Scientific Reports
28177906Myocardial protection from ischemia/reperfusion injury by exogenous galanin fragment.Timotin A, Pisarenko O, Sidorova M, Studneva I, Shulzhenko V, Palkeeva M, Serebryakova L, Molokoedov A, Veselova O, Cinato M, Tronchere H, Boal F, Kunduzova O.2017Oncotarget
27005319Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity.Boal F, Timotin A, Roumegoux J, Alfarano C, Calise D, Anesia R, Parini A, Valet P, Tronchere H, Kunduzova O.2016Br J Pharmacol
26776508PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment.Boal F, Puhar A, Xuereb JM, Kunduzova O, Sansonetti PJ, Payrastre B, Tronchère H.2016Cell Rep
25521429Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury.Pisarenko O, Shulzhenko V, Studneva I, Pelogeykina Y, Timoshin A, Anesia R, Valet P, Parini A, Kunduzova O.2015Br J Pharmacol
25027224Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin.Alfarano C, Foussal C, Lairez O, Calise D, Attané C, Anesia R, Daviaud D, Wanecq E, Parini A, Valet P, Kunduzova O.2015Int J Obes (Lond)
22028387Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O.2012Eur Heart J